MiNK Therapeutics
INKT
INKT
25 hedge funds and large institutions have $1.76M invested in MiNK Therapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
70% less capital invested
Capital invested by funds: $5.96M → $1.76M (-$4.2M)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$80K | |
| 2 | +$23.1K | |
| 3 | +$16.4K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$11K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.2K |
Top Sellers
| 1 | -$1.86M | |
| 2 | -$306K | |
| 3 | -$189K | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$94K |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$32.6K |